4 Patents
- US123527622025Dynamic of Sflt-1 or Endoglin/pigf Ratio as an Indicator for Imminent Preeclampsia And/or HELLP Syndrome
Roche Diagnostics Operations, Inc.
0 cites - US121050962024Ratios of Sflt-1 to P1GF or Endoglin to P1GF as Biomarkers for Preeclampsia Related Adverse Outcomes After Birth
Roche Diagnostics Operations, Inc.
0 cites - US120855732024Means and Methods Applying Sflt-1/plgf or Endoglin/plgf Ratio to Rule Out Onset of Preeclampsia Within a Certain Time Period
Roche Diagnostics Operations, Inc.
0 cites - 0 cites